TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
PharmInfo i Uppsala AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
203
|
435
|
711 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
156
|
236
|
374 |
| EBITDA |
189
|
267
|
465 |
| Total assets |
2,819
|
2,842
|
2,947 |
| Current assets |
2,488
|
2,821
|
2,878 |
| Current liabilities |
96
|
186
|
206 |
| Equity capital |
2,567
|
2,472
|
2,541 |
| - share capital |
101
|
95
|
98 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
91.1%
|
87.0%
|
86.2% |
| Turnover per employee |
203
|
435
|
711 |
| Profit as a percentage of turnover |
76.8%
|
54.3%
|
52.6% |
| Return on assets (ROA) |
5.5%
|
8.3%
|
12.7% |
| Current ratio |
2591.7%
|
1516.7%
|
1397.1% |
| Return on equity (ROE) |
6.1%
|
9.5%
|
14.7% |
| Change turnover |
-263
|
-254
|
711 |
| Change turnover % |
-57%
|
-37% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.